The new daily pill that promises to help you lose 12% by weight – a revolution in the struggle with obesity
A new revolutionary drug in the form of a daily pill promises to radically change how we treat obesity, providing an effective and convenient oral solution for weight loss.
Obesity frustration – a new oral pill promises solutions for weight loss shutterstock
In the context of the alarming growth of the obesity rate at the global level, this oral anti-Obity therapy brings hope to patients who seek alternatives to injectable treatments.
Clinical tests for the new oral treatment against obesity have shown that patients may lose around 12% of body weight within 72 weeks.
The manufacturer, the company Eli lillystates that the weight loss drug – still unlucky – could be available next year.
Pill, called Orphorglipronact by reducing appetite and inducing a feeling of satiety.
Next, you will discover how it works Orphorglipronwhat results the clinical tests have achieved, how to compare with the existing injections and what impact this pill could have on the weight loss drug market.
A new promising oral treatment for obesity: Orphlipron – action, benefits and results
The preliminary results of a study show that the pill Orphorglipron It can help patients lose 12 kilograms in 16 months, reducing appetite and inducing the feeling of satiety. However, about 1 in 10 participants gave up due to the adverse effects of weight loss treatment, including nausea and vomiting.
In addition to weight loss, participants also presented additional health benefits in the treatment of obesity, such as decreases in cholesterol levels, blood fats and blood pressure.
Dr. Kenneth Custer, representative of Eli lillysaid, being quoted by BBCthat the company intends to submit the licensing application before the end of the year and prepares “A global launch, to respond to this urgent need for public health.”
How to compare the Orphorpron pill with the injectable treatments existing on the market
The efficiency of the orphorglipron is lower than the injectable treatments. The average loss of 12% by weight in the case of pill is compared with a 22% discount for patients using Mounjaro (administered by weekly injection) – both products of Eli lilly.
Even if it is less effective, the pill has high chances of attracting an important market segment, as it offers an injections without injections to reduce obesity.
Advantages and disadvantages of oral pill for weight loss to injection treatments
Experts also hope that the oral version will be much cheaper than current injections, which would make it accessible to a larger number of patients. The full results of the study will be presented next month, in September 2025, at the annual meeting of European Association for the Study of Diabetes and subsequently published in a scientific magazine.
The rival producer Novo Nordisk has, in turn, an oral version of the injectable drug Wegovyalready submitted for approval in the US. In clinical tests, patients who have received the maximum dose of the daily pill Novo Nordisk They lost an average of 15% of body weight after 64 weeks.
The new innovative oral pill, competition with top injections, could radically change the options available for obesity patients, bringing a more accessible and comfortable treatment in the fight against excess weight.
